Literature DB >> 1530816

Hepatitis B in Canada: the case for universal vaccination. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1530816      PMCID： PMC1488203     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  11 in total

1.  Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal).

Authors:  P Maupas; J P Chiron; F Barin; P Coursaget; A Goudeau; J Perrin; F Denis; I D Mar
Journal:  Lancet       Date:  1981-02-07       Impact factor: 79.321

2.  Are booster doses of hepatitis B vaccine necessary?

Authors:  S C Hadler
Journal:  Ann Intern Med       Date:  1988-03       Impact factor: 25.391

Review 3.  Hepatitis B: global importance and need for control.

Authors:  J E Maynard
Journal:  Vaccine       Date:  1990-03       Impact factor: 3.641

4.  Hepatitis B vaccine in infants from an endemic area: long-term anti-HBs persistence and revaccination.

Authors:  B Yvonnet; P Coursaget; J Chotard; M Sarr; R NDoye; J P Chiron; I Diop-Mar
Journal:  J Med Virol       Date:  1987-08       Impact factor: 2.327

5.  Age- and sex-related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal).

Authors:  P Coursaget; B Yvonnet; J Chotard; P Vincelot; M Sarr; C Diouf; J P Chiron; I Diop-Mar
Journal:  J Med Virol       Date:  1987-05       Impact factor: 2.327

6.  The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies.

Authors:  M J Alter; S C Hadler; H S Margolis; W J Alexander; P Y Hu; F N Judson; A Mares; J K Miller; L A Moyer
Journal:  JAMA       Date:  1990-03-02       Impact factor: 56.272

7.  Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population.

Authors:  R B Wainwright; B J McMahon; L R Bulkow; D B Hall; M A Fitzgerald; A P Harpster; S C Hadler; A P Lanier; W L Heyward
Journal:  JAMA       Date:  1989-04-28       Impact factor: 56.272

8.  Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal).

Authors:  P Coursaget; B Yvonnet; J Chotard; M Sarr; P Vincelot; R N'doye; I Diop-Mar; J P Chiron
Journal:  Lancet       Date:  1986-11-15       Impact factor: 79.321

9.  Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men.

Authors:  S C Hadler; D P Francis; J E Maynard; S E Thompson; F N Judson; D F Echenberg; D G Ostrow; P M O'Malley; K A Penley; N L Altman
Journal:  N Engl J Med       Date:  1986-07-24       Impact factor: 91.245

10.  Hepatitis B virus infection among children born in the United States to Southeast Asian refugees.

Authors:  A L Franks; C J Berg; M A Kane; B B Browne; R K Sikes; W R Elsea; A H Burton
Journal:  N Engl J Med       Date:  1989-11-09       Impact factor: 91.245
View more
  5 in total

1.  Moving towards a universal hepatitis B vaccine program for Canadian children.

Authors:  N Macdonald
Journal:  Can J Infect Dis       Date:  1995-05

2.  Pediatric immunization for the 1990s.

Authors:  N Macdonald; R Gold; D Scheifele; V Marchessault
Journal:  Can J Infect Dis       Date:  1992-01

Review 3.  Pharmacoeconomics of immunisation: a review.

Authors:  R van den Oever; D de Graeve; B Hepp; A Stroobant; D Walckiers; V Van Casteren; F Van Loock; G Ducoffre; J Dewatripont; P Jacques
Journal:  Pharmacoeconomics       Date:  1993-04       Impact factor: 4.981

4.  Prevention of perinatal hepatitis B virus transmission in an obstetric/infant population.

Authors:  P J Parker; T W Gyorkos; J S Dylewski; A K Joshi; E D Franco
Journal:  Can J Infect Dis       Date:  1993-09

5.  Viral hepatitis: retrospective review in a canadian pediatric hospital.

Authors:  Paulina Cybulska; Andy Ni; Carolina Jimenez-Rivera
Journal:  ISRN Pediatr       Date:  2010-12-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.